
Christopher Brian Mckinley
Examiner (ID: 13265)
| Most Active Art Unit | 3781 |
| Art Unit(s) | 3781 |
| Total Applications | 591 |
| Issued Applications | 270 |
| Pending Applications | 9 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14467593
[patent_doc_number] => 20190185439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => RADIOFLUORINATED CARBOXIMIDAMIDES AS IDO TARGETING PET TRACER FOR CANCER IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/327372
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327372 | RADIOFLUORINATED CARBOXIMIDAMIDES AS IDO TARGETING PET TRACER FOR CANCER IMAGING | Aug 23, 2017 | Abandoned |
Array
(
[id] => 16499833
[patent_doc_number] => 10865207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Compounds for imaging Tau protein aggregates
[patent_app_type] => utility
[patent_app_number] => 16/319808
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 18879
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319808
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319808 | Compounds for imaging Tau protein aggregates | Jul 20, 2017 | Issued |
Array
(
[id] => 16443720
[patent_doc_number] => 10835624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Compounds for imaging Tau protein aggregates
[patent_app_type] => utility
[patent_app_number] => 16/319817
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 23317
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319817
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319817 | Compounds for imaging Tau protein aggregates | Jul 20, 2017 | Issued |
Array
(
[id] => 14864945
[patent_doc_number] => 20190282714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME
[patent_app_type] => utility
[patent_app_number] => 16/318209
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318209
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318209 | RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME | Jul 17, 2017 | Abandoned |
Array
(
[id] => 14621947
[patent_doc_number] => 20190224341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => RENAL CLEARABLE ORGANIC NANOCARRIERS
[patent_app_type] => utility
[patent_app_number] => 16/314149
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314149
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/314149 | RENAL CLEARABLE ORGANIC NANOCARRIERS | Jun 28, 2017 | Abandoned |
Array
(
[id] => 13716999
[patent_doc_number] => 20170369454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/635776
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15635776
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/635776 | 18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS | Jun 27, 2017 | Abandoned |
Array
(
[id] => 17095487
[patent_doc_number] => 20210283278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => CHIRAL CYCLEN COMPOUNDS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 16/334464
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334464
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/334464 | Chiral cyclen compounds and their uses | Jun 22, 2017 | Issued |
Array
(
[id] => 15020983
[patent_doc_number] => 20190321496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => AGENTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH EXTRACELLULAR MATRIX TURNOVER
[patent_app_type] => utility
[patent_app_number] => 16/310282
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310282
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310282 | AGENTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH EXTRACELLULAR MATRIX TURNOVER | Jun 15, 2017 | Abandoned |
Array
(
[id] => 14744051
[patent_doc_number] => 20190255199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => NON-INVASIVE DIAGNOSTIC IMAGING AGENT FOR HEART DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/308014
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308014
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308014 | NON-INVASIVE DIAGNOSTIC IMAGING AGENT FOR HEART DISEASE | Jun 8, 2017 | Abandoned |
Array
(
[id] => 14926455
[patent_doc_number] => 20190298865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => RADIO-PHARMACEUTICAL COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 16/308307
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308307 | RADIO-PHARMACEUTICAL COMPLEXES | Jun 5, 2017 | Abandoned |
Array
(
[id] => 15895449
[patent_doc_number] => 20200147243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => LIGAND COMPOUND OF ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/617851
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617851
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617851 | LIGAND COMPOUND OF ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AND APPLICATION THEREOF | Jun 5, 2017 | Abandoned |
Array
(
[id] => 12137103
[patent_doc_number] => 20180015186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'Compositions And Methods For In Vivo Imaging'
[patent_app_type] => utility
[patent_app_number] => 15/581386
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18676
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581386
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/581386 | Compositions and methods for in vivo imaging | Apr 27, 2017 | Issued |
Array
(
[id] => 16087115
[patent_doc_number] => 20200197544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => JCV IMAGING METHODS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/608792
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608792
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608792 | JCV IMAGING METHODS AND COMPOSITIONS | Apr 25, 2017 | Abandoned |
Array
(
[id] => 11742927
[patent_doc_number] => 20170196999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'Treatment of Meningiomas Using Phenylbenzothiazole, Stilbene, Biphenylalkyne, or Pyridine Derivitives'
[patent_app_type] => utility
[patent_app_number] => 15/472763
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18728
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15472763
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/472763 | Treatment of meningiomas using phenylbenzothiazole, stilbene, biphenylalkyne, or pyridine derivatives | Mar 28, 2017 | Issued |
Array
(
[id] => 16310928
[patent_doc_number] => 20200289666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/089787
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089787
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089787 | BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY | Mar 27, 2017 | Abandoned |
Array
(
[id] => 16288940
[patent_doc_number] => 10765763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Radioligands for myelin
[patent_app_type] => utility
[patent_app_number] => 16/083747
[patent_app_country] => US
[patent_app_date] => 2017-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 26
[patent_no_of_words] => 25406
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083747 | Radioligands for myelin | Mar 8, 2017 | Issued |
Array
(
[id] => 16108695
[patent_doc_number] => 20200206370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => 18F-LABELED BISPHOSPHONATES FOR PET IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/303913
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303913
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303913 | 18F-LABELED BISPHOSPHONATES FOR PET IMAGING | Mar 6, 2017 | Abandoned |
Array
(
[id] => 11706130
[patent_doc_number] => 20170174629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'USE OF FLUORINATED DERIVATIVES OF 4-AMINOPYRIDINE IN THERAPEUTICS AND MEDICAL IMAGING'
[patent_app_type] => utility
[patent_app_number] => 15/452179
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 25893
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15452179
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/452179 | Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging | Mar 6, 2017 | Issued |
Array
(
[id] => 13955707
[patent_doc_number] => 20190054197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => RADIOLABELED MACROCYCLIC EGFR INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/080196
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16080196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/080196 | Radiolabeled macrocyclic EGFR inhibitor | Feb 27, 2017 | Issued |
Array
(
[id] => 13926305
[patent_doc_number] => 20190046668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => RADIOLABELED MONOACYLGLYCEROL LIPASE OCCUPANCY PROBE
[patent_app_type] => utility
[patent_app_number] => 15/999117
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999117 | Radiolabeled monoacylglycerol lipase occupancy probe | Feb 16, 2017 | Issued |